BioCentury
ARTICLE | Financial News

Myriad unveils $200M share buyback

February 6, 2013 1:52 AM UTC

Myriad Genetics Inc. (NASDAQ:MYGN) said its board authorized a $200 million share repurchase program. The company also said it repurchased 1.2 million shares in 4Q12 for $33.7 million under a previous...